IOVEarnings•globenewswire•
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
Sentiment:Positive (70)
Summary
$60.0M in 2Q25 Total Product Revenue
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 7, 2025 by globenewswire